UA35656C2 - Method for treating continuously progressive psychic diseases leading to dementia - Google Patents

Method for treating continuously progressive psychic diseases leading to dementia

Info

Publication number
UA35656C2
UA35656C2 UA99127123A UA99127123A UA35656C2 UA 35656 C2 UA35656 C2 UA 35656C2 UA 99127123 A UA99127123 A UA 99127123A UA 99127123 A UA99127123 A UA 99127123A UA 35656 C2 UA35656 C2 UA 35656C2
Authority
UA
Ukraine
Prior art keywords
dementia
diseases leading
continuously progressive
treating
psychic diseases
Prior art date
Application number
UA99127123A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Євген Рувимович Гасуль
Евгений Рувимович Гасуль
Олександр Миколайович Макаренко
Александр Николаевич Макаренко
Петро Олександрович Макаренко
Петр Александрович Макаренко
Original Assignee
Олександр Миколайович Макаренко
Александр Николаевич Макаренко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Олександр Миколайович Макаренко, Александр Николаевич Макаренко filed Critical Олександр Миколайович Макаренко
Priority to UA99127123A priority Critical patent/UA35656C2/en
Publication of UA35656C2 publication Critical patent/UA35656C2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to the medicine, namely to psychoneurology and may be used for treating the continuously progressive psychic diseases leading to dementia such as schizophrenia, Alzheimer disease, the senile dementia of Alzheimer-like type, Niemann-Pick disease etc. The method for treating the continuously progressive psychic diseases leading to dementia comprises the intravenous and/or intramuscular administration of blood plasma that is selected on the genetic basis. The duration of the treatment depends on the time required for the stable elimination of the pathology and the recovery of the lost abilities.
UA99127123A 1999-12-27 1999-12-27 Method for treating continuously progressive psychic diseases leading to dementia UA35656C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA99127123A UA35656C2 (en) 1999-12-27 1999-12-27 Method for treating continuously progressive psychic diseases leading to dementia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA99127123A UA35656C2 (en) 1999-12-27 1999-12-27 Method for treating continuously progressive psychic diseases leading to dementia

Publications (1)

Publication Number Publication Date
UA35656C2 true UA35656C2 (en) 2001-04-16

Family

ID=74181655

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99127123A UA35656C2 (en) 1999-12-27 1999-12-27 Method for treating continuously progressive psychic diseases leading to dementia

Country Status (1)

Country Link
UA (1) UA35656C2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10245285B2 (en) 2016-04-28 2019-04-02 Alkahest, Inc. Blood plasma and plasma fractions as therapy for tumor growth and progression
US10357513B2 (en) 2017-04-26 2019-07-23 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
US10487148B2 (en) 2010-01-28 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated impairments
US10617744B2 (en) 2015-06-15 2020-04-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated conditions
US10626399B2 (en) 2010-01-28 2020-04-21 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
US10688154B2 (en) 2011-04-08 2020-06-23 The Board Of Trustees Of The Leland Stanford Junior University Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
US10688130B2 (en) 2013-12-09 2020-06-23 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated conditions
US10905779B2 (en) 2013-12-09 2021-02-02 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening human blood products comprising plasma using immunocompromised rodent models
US11040068B2 (en) 2017-04-26 2021-06-22 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
US11103530B2 (en) 2018-10-26 2021-08-31 Alkahest, Inc. Methods of improving or accelerating postoperative recovery
US11236340B2 (en) 2010-01-28 2022-02-01 The Board Of Trustees Of The Leland Stanford Junior University Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11912998B2 (en) 2010-01-28 2024-02-27 The Board Of Trustees Of The Leland Stanford Junior University Method of treating aging-associated cognitive impairment by reducing CCR3
US10487148B2 (en) 2010-01-28 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated impairments
US11236340B2 (en) 2010-01-28 2022-02-01 The Board Of Trustees Of The Leland Stanford Junior University Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3)
US10626399B2 (en) 2010-01-28 2020-04-21 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
US10688154B2 (en) 2011-04-08 2020-06-23 The Board Of Trustees Of The Leland Stanford Junior University Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
US10905779B2 (en) 2013-12-09 2021-02-02 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening human blood products comprising plasma using immunocompromised rodent models
US10688130B2 (en) 2013-12-09 2020-06-23 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated conditions
US11141469B2 (en) 2015-06-15 2021-10-12 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated conditions
US10617744B2 (en) 2015-06-15 2020-04-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated conditions
US10245285B2 (en) 2016-04-28 2019-04-02 Alkahest, Inc. Blood plasma and plasma fractions as therapy for tumor growth and progression
US10905717B2 (en) 2016-04-28 2021-02-02 Alkahest, Inc. Blood plasma and plasma fractions as therapy for tumor growth and progression
US10874692B2 (en) 2017-04-26 2020-12-29 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
US11040068B2 (en) 2017-04-26 2021-06-22 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
US11413308B2 (en) 2017-04-26 2022-08-16 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
US10357513B2 (en) 2017-04-26 2019-07-23 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
US11103530B2 (en) 2018-10-26 2021-08-31 Alkahest, Inc. Methods of improving or accelerating postoperative recovery
US11298377B2 (en) 2018-10-26 2022-04-12 Alkahest, Inc. Methods of improving wound healing
US11547724B2 (en) 2018-10-26 2023-01-10 Alkahest, Inc. Methods of treating a subject for pain

Similar Documents

Publication Publication Date Title
HUT74004A (en) Inhibitors of beta-amyloid protein production
WO2004000387A3 (en) Dialysis system for treatment of vulnerable patients and methods of use
WO2005065383A3 (en) Oxidative reductive potential water solution, processes for producing same and methods of using the same
DE60317562D1 (en) BENZOFURANDERIVATE, METHOD FOR THE PRODUCTION AND INTERMEDIATE PRODUCTS THEREOF
UA35656C2 (en) Method for treating continuously progressive psychic diseases leading to dementia
HK1087398A1 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
MY135838A (en) Methods for the treatment of mental disorders
ATE435026T1 (en) METHOD FOR PREVENTION AND TREATMENT OF DIABETES USING NEURTURIN
MXPA03009849A (en) Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases.
HU213677B (en) Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
UA27102C2 (en) Composition for stabilization of blood plasma in the process of pasteurization, method of plasma pasteurization and drug for therapy by plasma medication
GB0020504D0 (en) Therapeutic method
DE60032590D1 (en) METHOD FOR TREATING SCHIZOPHRENIA
TW200510437A (en) Phosphinane compound with immunomodulating activity
ATE285773T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
DE3787437D1 (en) SIALOSYL CHOLESTEROL, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM.
DK82892D0 (en) APPLICATION OF BRAIN ADDITION FROM BEES AND WHEPS FOR THE PREPARATION OF MEDICINAL PRODUCTS TO TREAT INFECTIONS
HUP0103660A2 (en) Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid
WO2002017917A8 (en) Manzamines for treatment of drug resistant infection
IL117083A0 (en) Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical agents containing these compounds
WO2006041838A3 (en) Heparinoid compositions for treatment and prevention of dementia
AU2396900A (en) Treatment and prevention of hiv and other viral infections
UA29106A (en) The method for treatment of vibration disease
WO2003066806A3 (en) Therapeutic use of aziridino compounds
IL165996A0 (en) Novel thiophene acyl hydrazino derivatives method for preparing same use thereof as medicines pharmaceutical compositions and novel use